Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 55/100

Failure Rate

20.0%

1 terminated/withdrawn out of 5 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

40%

2 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 3
2(66.7%)
N/A
1(33.3%)
3Total
Phase 3(2)
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT04191590Not ApplicableWithdrawn

Impact of Chronic Rhinosinusitis on the Index of Ciliary Beat Efficiency Using Fluorescent Nanosticks: (R-IMPAC)

Role: collaborator

NCT04641195Phase 3Completed

Vitamin D and Zinc Supplementation for Improving Treatment Outcomes Among COVID-19 Patients in India

Role: collaborator

NCT04631965Unknown

Healthcare Transition of Adolescents With Chronic Health Conditions

Role: collaborator

NCT04342598Completed

Case Control Study of Vitamin D Status and Adult Multidrug-resistant Pulmonary Tuberculosis in Maharashtra, India

Role: collaborator

NCT00666744Phase 3Unknown

A Randomised Controlled Trial of Family Mediated Exercises (FAME) Following Stroke

Role: collaborator

All 5 trials loaded